Rhumbline Advisers Sells 9,522 Shares of Humana Inc. (NYSE:HUM)

Rhumbline Advisers cut its position in Humana Inc. (NYSE:HUM) by 3.8% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 238,128 shares of the insurance provider’s stock after selling 9,522 shares during the quarter. Rhumbline Advisers owned about 0.20% of Humana worth $60,415,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in the company. FNY Investment Advisers LLC raised its holdings in Humana by 6,647.5% in the 4th quarter. FNY Investment Advisers LLC now owns 27,260 shares of the insurance provider’s stock valued at $6,916,000 after acquiring an additional 26,856 shares in the last quarter. Retirement Systems of Alabama raised its holdings in Humana by 735.9% in the 4th quarter. Retirement Systems of Alabama now owns 219,002 shares of the insurance provider’s stock valued at $55,563,000 after acquiring an additional 192,801 shares in the last quarter. PDT Partners LLC raised its holdings in Humana by 190.0% in the 3rd quarter. PDT Partners LLC now owns 4,060 shares of the insurance provider’s stock valued at $1,286,000 after acquiring an additional 2,660 shares in the last quarter. Secure Asset Management LLC acquired a new position in Humana in the 4th quarter valued at $244,000. Finally, Ontario Teachers Pension Plan Board raised its holdings in Humana by 6.5% in the 3rd quarter. Ontario Teachers Pension Plan Board now owns 1,173,535 shares of the insurance provider’s stock valued at $371,705,000 after acquiring an additional 71,910 shares in the last quarter. 92.38% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Humana

In other Humana news, insider Timothy S. Huval sold 3,703 shares of the company’s stock in a transaction dated Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total value of $948,930.78. Following the sale, the insider now owns 8,181 shares in the company, valued at approximately $2,096,463.06. The trade was a 31.16 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Corporate insiders own 0.32% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have weighed in on HUM. Truist Financial lifted their price objective on Humana from $260.00 to $290.00 and gave the company a “hold” rating in a report on Monday, January 6th. Piper Sandler lifted their price objective on Humana from $270.00 to $288.00 and gave the company a “neutral” rating in a report on Wednesday, January 15th. Barclays boosted their price target on Humana from $255.00 to $270.00 and gave the stock an “equal weight” rating in a report on Thursday. Cantor Fitzgerald reissued a “neutral” rating and set a $290.00 price target on shares of Humana in a report on Wednesday, February 12th. Finally, Bank of America raised Humana from an “underperform” rating to a “neutral” rating and boosted their price target for the stock from $247.00 to $308.00 in a report on Wednesday, November 6th. Nineteen research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $293.05.

Humana Trading Up 0.3 %

NYSE HUM opened at $253.61 on Monday. The business’s 50-day moving average price is $271.27 and its two-hundred day moving average price is $293.44. Humana Inc. has a 12 month low of $213.31 and a 12 month high of $406.46. The firm has a market capitalization of $30.54 billion, a PE ratio of 22.46, a price-to-earnings-growth ratio of 2.11 and a beta of 0.56. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.67.

Humana (NYSE:HUM) last released its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, beating analysts’ consensus estimates of ($2.26) by $0.10. Humana had a return on equity of 13.20% and a net margin of 1.18%. On average, analysts expect that Humana Inc. will post 16.11 EPS for the current year.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.